These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30950568)

  • 1. Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study.
    Liedberg F; Hagberg O; Aljabery F; Gårdmark T; Hosseini A; Jahnson S; Jancke G; Jerlström T; Malmström PU; Sherif A; Ströck V; Häggström C; Holmberg L
    BJU Int; 2019 Sep; 124(3):449-456. PubMed ID: 30950568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer.
    Richters A; Ripping TM; Kiemeney LA; Leliveld AM; van Rhijn BWG; Oddens JR; van Moorselaar RJA; Goossens-Laan CA; Meijer RP; Boormans JL; ; Witjes JA; Aben KKH
    BJU Int; 2021 Oct; 128(4):511-518. PubMed ID: 33404154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy.
    Chalfin HJ; Liu JJ; Gandhi N; Feng Z; Johnson D; Netto GJ; Drake CG; Hahn NM; Schoenberg MP; Trock BJ; Scott AV; Frank SM; Bivalacqua TJ
    Ann Surg Oncol; 2016 Aug; 23(8):2715-22. PubMed ID: 27012987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delays in radical cystectomy for muscle-invasive bladder cancer.
    Chu AT; Holt SK; Wright JL; Ramos JD; Grivas P; Yu EY; Gore JL
    Cancer; 2019 Jun; 125(12):2011-2017. PubMed ID: 30840335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital-specific probability of cystectomy affects survival from muscle-invasive bladder cancer.
    Ripping TM; Witjes JA; Meijer RP; van Rhijn BWG; Oddens JR; Goossens-Laan CA; Mulder SF; van Moorselaar RJA; Kiemeney LA; Aben KKH
    Urol Oncol; 2020 Dec; 38(12):935.e9-935.e16. PubMed ID: 32917503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
    Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
    Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.
    Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA
    Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital volume and perioperative outcomes for radical cystectomy: a population study.
    Udovicich C; Perera M; Huq M; Wong LM; Lenaghan D
    BJU Int; 2017 May; 119 Suppl 5():26-32. PubMed ID: 28544301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher surgeon and hospital volume improves long-term survival after radical cystectomy.
    Kulkarni GS; Urbach DR; Austin PC; Fleshner NE; Laupacis A
    Cancer; 2013 Oct; 119(19):3546-54. PubMed ID: 23839861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': the case for super centralisation.
    Afshar M; Goodfellow H; Jackson-Spence F; Evison F; Parkin J; Bryan RT; Parsons H; James ND; Patel P
    BJU Int; 2018 Feb; 121(2):217-224. PubMed ID: 28594471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
    Cahn DB; Handorf EA; Ghiraldi EM; Ristau BT; Geynisman DM; Churilla TM; Horwitz EM; Sobczak ML; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2017 Nov; 123(22):4337-4345. PubMed ID: 28743162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle-invasive bladder cancer.
    Ritch CR; Balise R; Prakash NS; Alonzo D; Almengo K; Alameddine M; Venkatramani V; Punnen S; Parekh DJ; Gonzalgo ML
    BJU Int; 2018 May; 121(5):745-751. PubMed ID: 29281848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort.
    Vetterlein MW; Meyer CP; Leyh-Bannurah SR; Mayr R; Gierth M; Fritsche HM; Burger M; Keck B; Wullich B; Martini T; Bolenz C; Pycha A; Hanske J; Roghmann F; Noldus J; Bastian PJ; Gilfrich C; May M; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Clin Genitourin Cancer; 2017 Oct; 15(5):e809-e817. PubMed ID: 28550955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel.
    Bruins HM; Veskimäe E; Hernández V; Neuzillet Y; Cathomas R; Compérat EM; Cowan NC; Gakis G; Espinós EL; Lorch A; Ribal MJ; Rouanne M; Thalmann GN; Yuan Y; der Heijden AGV; Witjes JA
    Eur Urol Oncol; 2020 Apr; 3(2):131-144. PubMed ID: 31866215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital Quality Metrics for Radical Cystectomy: Disease Specific and Correlated to Mortality Outcomes.
    Khanna A; Saarela O; Lawson K; Finelli A; Haber GP; Lee B; Abouassaly R
    J Urol; 2019 Sep; 202(3):490-497. PubMed ID: 31009290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate.
    Goossens-Laan CA; Gooiker GA; van Gijn W; Post PN; Bosch JL; Kil PJ; Wouters MW
    Eur Urol; 2011 May; 59(5):775-83. PubMed ID: 21310525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study.
    Porter MP; Gore JL; Wright JL
    World J Urol; 2011 Feb; 29(1):73-7. PubMed ID: 21132553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis.
    Leow JJ; Reese S; Trinh QD; Bellmunt J; Chung BI; Kibel AS; Chang SL
    BJU Int; 2015 May; 115(5):713-21. PubMed ID: 24674655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.
    Rosenblatt R; Sherif A; Rintala E; Wahlqvist R; Ullén A; Nilsson S; Malmström PU;
    Eur Urol; 2012 Jun; 61(6):1229-38. PubMed ID: 22189383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe).
    Häggström C; Liedberg F; Hagberg O; Aljabery F; Ströck V; Hosseini A; Gårdmark T; Sherif A; Malmström PU; Garmo H; Jahnson S; Holmberg L
    BMJ Open; 2017 Sep; 7(9):e016606. PubMed ID: 28963292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.